Seely Lynn bought LYEL
February 9, 2026 · Form 4 insider transaction
Seely Lynn bought 20,000 shares of Lyell Immunopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderSeely Lynn
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after82,159
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Pursuant to performance-based restricted stock units granted to the reporting person on February 9, 2024, 20,000 shares were issued on the Transaction Date upon the achievement of certain performance criteria certified by the compensation committee of the Issuer's board of directors on the Transaction Date.